Core Laboratories (CLB) Tops Q4 EPS by 2c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2021 RESULTS FROM CONTINUING OPERATIONS:
February 2, 2022 5:15 PM ESTAMSTERDAM, Feb. 2, 2022 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported fourth quarter 2021 revenue of $125,100,000. Core's operating income was $14,200,000, yielding operating margins of 11%, with earnings per diluted share ("EPS") of $0.06, all in accordance with U.S. generally accepted accounting principles ("GAAP"). EPS, ex-items, a non-GAAP financial measure, was $0.20. Income tax expense in the fourth quarter of 2021 was elevated primarily due to significant fluctuations in foreign currency exchange rates. A full reconciliation of non-GAAP financial measures and year-over-year comparisons are included in the attached financial... More
